FDx Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $324K | Buy |
+2,690
| New | +$311K | 0.1% | 125 |
|
|
2024
Q4 | – | Sell |
-2,896
| Closed | -$329K | – | 197 |
|
|
2024
Q3 | $329K | Sell |
2,896
-2
| -0.1% | -$238 | 0.09% | 141 |
|
|
2024
Q2 | $359K | Sell |
2,898
-35,526
| -92% | -$4.58M | 0.1% | 127 |
|
|
2024
Q1 | $5.07M | Sell |
38,424
-21,676
| -36% | -$2.67M | 0.77% | 30 |
|
|
2023
Q4 | $6.55M | Sell |
60,100
-15,555
| -21% | -$1.61M | 0.51% | 43 |
|
|
2023
Q3 | $7.79M | Sell |
75,655
-83,972
| -53% | -$9.05M | 0.65% | 35 |
|
|
2023
Q2 | $18.4M | Sell |
159,627
-32,982
| -17% | -$3.74M | 1.01% | 19 |
|
|
2023
Q1 | $21.4M | Hold |
192,609
| – | – | 0.93% | 21 |
|
|
2022
Q4 | $21.4M | Sell |
192,609
-6,138
| -3% | -$627K | 0.93% | 21 |
|
|
2022
Q3 | $17.1M | Sell |
198,747
-39
| -0% | -$3.48K | 0.77% | 26 |
|
|
2022
Q2 | $18.1M | Buy |
198,786
+3,068
| +2% | +$272K | 0.68% | 28 |
|
|
2022
Q1 | $16.1M | Sell |
195,718
-46,180
| -19% | -$3.64M | 0.54% | 37 |
|
|
2021
Q4 | $18.5M | Buy |
241,898
+13,277
| +6% | +$1.06M | 0.51% | 44 |
|
|
2021
Q3 | $17.2M | Buy |
228,621
+13,228
| +6% | +$1.01M | 0.55% | 41 |
|
|
2021
Q2 | $16.8M | Buy |
215,393
+30,558
| +17% | +$2.27M | 0.56% | 37 |
|
|
2021
Q1 | $13.6M | Buy |
184,835
+9,178
| +5% | +$677K | 0.51% | 43 |
|
|
2020
Q4 | $13.7M | Buy |
175,657
+20,787
| +13% | +$1.59M | 0.57% | 41 |
|
|
2020
Q3 | $12.3M | Buy |
154,870
+27,040
| +21% | +$2.12M | 0.57% | 44 |
|
|
2020
Q2 | $9.43M | Buy |
127,830
+37,531
| +42% | +$2.83M | 0.49% | 49 |
|
|
2020
Q1 | $6.63M | Buy |
90,299
+37,846
| +72% | +$2.97M | 0.43% | 58 |
|
|
2019
Q4 | $4.55M | Buy |
52,453
+578
| +1% | +$47.5K | 0.25% | 93 |
|
|
2019
Q3 | $4.17M | Sell |
51,875
-14,929
| -22% | -$1.2M | 0.29% | 77 |
|
|
2019
Q2 | $5.34M | Buy |
66,804
+7,920
| +13% | +$606K | 0.21% | 98 |
|
|
2019
Q1 | $4.67M | Buy |
58,884
+21,701
| +58% | +$1.62M | 0.19% | 100 |
|
|
2018
Q4 | $2.71M | Sell |
37,183
-28,972
| -44% | -$2.05M | 0.22% | 81 |
|
|
2018
Q3 | $4.48M | Sell |
66,155
-14,867
| -18% | -$947K | 0.17% | 100 |
|
|
2018
Q2 | $4.69M | Sell |
81,022
-98,149
| -55% | -$5.54M | 0.17% | 98 |
|
|
2018
Q1 | $9.31M | Sell |
179,171
-27,850
| -13% | -$1.5M | 0.28% | 72 |
|
|
2017
Q4 | $11.1M | Sell |
207,021
-4,704
| -2% | -$261K | 0.3% | 60 |
|
|
2017
Q3 | $12.9M | Buy |
211,725
+7,636
| +4% | +$463K | 0.36% | 51 |
|
|
2017
Q2 | $12.5M | Sell |
204,089
-288
| -0.1% | -$17.5K | 0.37% | 49 |
|
|
2017
Q1 | $12.4M | Sell |
204,377
-7,989
| -4% | -$485K | 0.38% | 50 |
|
|
2016
Q4 | $11.9M | Buy |
212,366
+43,140
| +25% | +$2.52M | 0.34% | 58 |
|
|
2016
Q3 | $10.1M | Buy |
169,226
+4,064
| +2% | +$238K | 0.42% | 42 |
|
|
2016
Q2 | $9.08M | Buy |
165,162
+19,297
| +13% | +$1.03M | 0.41% | 43 |
|
|
2016
Q1 | $7.36M | Buy |
145,865
+54,774
| +60% | +$2.68M | 0.34% | 65 |
|
|
2015
Q4 | $4.59M | Buy |
91,091
+33,508
| +58% | +$1.69M | 0.21% | 95 |
|
|
2015
Q3 | $2.71M | Sell |
57,583
-10,206
| -15% | -$542K | 0.23% | 81 |
|
|
2015
Q2 | $3.7M | Buy |
67,789
+2,079
| +3% | +$117K | 0.18% | 99 |
|
|
2015
Q1 | $3.6M | Buy |
65,710
+11,340
| +21% | +$642K | 0.08% | 202 |
|
|
2014
Q4 | $2.95M | Buy |
54,370
+14,245
| +36% | +$794K | 0.18% | 97 |
|
|
2014
Q3 | $2.27M | Sell |
40,125
-918
| -2% | -$51.5K | 0.15% | 141 |
|
|
2014
Q2 | $2.27M | Buy |
41,043
+16,265
| +66% | +$887K | 0.15% | 146 |
|
|
2014
Q1 | $1.34M | Buy |
24,778
+7,395
| +43% | +$383K | 0.11% | 188 |
|
|
2013
Q4 | $834K | Sell |
17,383
-2,896
| -14% | -$132K | 0.08% | 233 |
|
|
2013
Q3 | $921K | Buy |
20,279
+1,760
| +10% | +$80.4K | 0.11% | 175 |
|
|
2013
Q2 | $821K | Buy |
+18,519
| New | +$827K | 0.11% | 172 |
|
Other funds holding MRK
VCM
VPM
FDx Advisors's MRK Position: Q1 2026 in Review
FDx Advisors opened a new position in Merck (MRK) in Q1 2026: 2,690 shares worth $324K. The stake represents 0.1% of the portfolio and ranks #125 among its holdings. This is a return to the name: FDx Advisors previously reported a position in MRK as recently as Q3 2024.
FDx Advisors first reported a position in MRK in Q2 2013 and has held it in 47 quarters since. The position peaked at $21.4M in Q1 2023. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- FDx Advisors held 2,690 shares of Merck worth $324K as of Q1 2026.
- Merck was a new FDx Advisors position in Q1 2026.
- Merck made up 0.1% of FDx Advisors's portfolio in Q1 2026, its #125 holding.
- FDx Advisors first reported a position in Merck in Q2 2013 and has held it in 47 quarters since.
- FDx Advisors's Merck position peaked at $21.4M in Q1 2023.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on FDx Advisors's 13F filing for Q1 2026, filed 1 May 2026.